This results in persistent swelling and the formation of subcutaneous lumps
Similarly, BPC-157 has been shown to prevent other side effects of psychiatric medications, including severe side effects like catalepsy and somatosensory disturbance [15]
Drucker has found that the cells in the gut that produce GLP-1 seem to detect pathogens, releasing the hormone as part of the bodys response to injury or infection
Magnesium and the regulation of muscle contraction
Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments